Exhibitor-Hosted Program
From Study Execution to IND Readiness: AI Powered Nonclinical Drug Development
- Date and time
- Monday, November 16, 2026
- 12:00–12:55 PM CT
- Room
- Grand Oaks Ballroom, Level 2, Suite O
- JW Marriott San Antonio Hill Country Resort & Spa
AI implementation readiness requires structured, traceable study data. This session shows how TurboLIMS helps study directors make better decisions faster, and how AI benchmarking of biological responses against FDA-approved medications strengthens IND preparation. Includes live use cases.
What you will learn
- Data governance that makes study data ready for AI
- Validation practices for AI in regulated nonclinical work
- Traceability from instrument to report, with full audit trails
- What regulators expect when AI is part of the workflow
- How to put AI into daily operations safely, one task at a time
Part 4 · Anil Gunturu
AI, Now and Next
How much should the AI decide? Choosing AI with care in regulated nonclinical work.
Read our AI approachPresenters from Resero
David Watson, Ph.D.Chief Executive Officer
Taylor ScottProduct Manager
Anil GunturuChief Technology Officer
